Prolonged clinically asymptomatic evolution after HIV-1 infection is marked by the absence of complement C4 null alleles at the MHC
- PMID: 1572087
- PMCID: PMC1554293
- DOI: 10.1111/j.1365-2249.1992.tb03067.x
Prolonged clinically asymptomatic evolution after HIV-1 infection is marked by the absence of complement C4 null alleles at the MHC
Abstract
The length of time after which persons infected with HIV-1 progress to AIDS is variable. Certain alleles at the MHC have been shown to influence negatively the clinical outcome of HIV-1-infected persons and to be associated with special clinical manifestations. We investigated the MHC class I, class II and class III antigens in 54 Caucasian HIV-1-infected persons. The MHC profile of individuals with a prolonged period before AIDS is marked by a lower frequency of C4 null alleles.
Similar articles
-
Major histocompatibility complex genes influence the outcome of HIV infection. Ancestral haplotypes with C4 null alleles explain diverse HLA associations.Hum Immunol. 1990 Dec;29(4):282-95. doi: 10.1016/0198-8859(90)90042-n. Hum Immunol. 1990. PMID: 1981061
-
Bf S gene frequency in Nigerians with HIV infection.Dis Markers. 1991 Nov-Dec;9(6):333-8. Dis Markers. 1991. PMID: 1823312
-
Influence of C4 null genes on infection with human immunodeficiency virus.Br Med J (Clin Res Ed). 1988 Jun 11;296(6637):1627-8. doi: 10.1136/bmj.296.6637.1627. Br Med J (Clin Res Ed). 1988. PMID: 3135045 Free PMC article.
-
Interactions between major histocompatibility complex class II surface expression and HIV: implications for pathogenesis.Eur J Clin Invest. 2001 Nov;31(11):984-91. doi: 10.1046/j.1365-2362.2001.00895.x. Eur J Clin Invest. 2001. PMID: 11737241 Review.
-
[Genetic determinant factors of resistance to HIV infection and of control of progression to AIDS: implications on pathogenesis and therapeutic approaches for the eradication of HIV. A review].Rev Invest Clin. 2000 May-Jun;52(3):284-95. Rev Invest Clin. 2000. PMID: 10953612 Review. Spanish.
Cited by
-
Complement activation by human monoclonal antibodies to human immunodeficiency virus.J Virol. 1993 Jan;67(1):53-9. doi: 10.1128/JVI.67.1.53-59.1993. J Virol. 1993. PMID: 7677959 Free PMC article.
-
Protective immune responses against West Nile virus are primed by distinct complement activation pathways.J Exp Med. 2006 May 15;203(5):1371-81. doi: 10.1084/jem.20052388. Epub 2006 May 1. J Exp Med. 2006. PMID: 16651386 Free PMC article.
-
Immunoglobulins and complement factor C4 in adult rhinosinusitis.Clin Exp Immunol. 2006 Aug;145(2):219-27. doi: 10.1111/j.1365-2249.2006.03134.x. Clin Exp Immunol. 2006. PMID: 16879240 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous